Search results
Pfizer pauses phase 3 dosing in gene therapy trial after young boy's death
FierceBiotech· 12 hours agoA young boy with Duchenne muscular dystrophy (DMD) participating in Pfizer’s phase 2 gene therapy...
Pfizer to test third dose of COVID-19 vaccine in children
AOL· 3 hours agoThe decision was made after an analysis showed the two-dose vaccine generated an immune response in...
Pfizer Pauses Gene Therapy Trial for Muscle Disease After Death
Bloomberg· 12 hours agoPfizer Inc. paused a study of an experimental gene therapy for muscular dystrophy after a child who...
Pfizer wants the $75 mln left from SAC Capital’s insider trading settlement with SEC
Reuters· 12 hours agoPharma company Pfizer told a New York federal judge on Monday that it is entitled to recoup about...
Pfizer reports patient death in Duchenne gene therapy study
Reuters via AOL· 11 hours ago(Reuters) -A young patient died due to cardiac arrest after receiving Pfizer's experimental gene...
Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend
Simply Wall St. via Yahoo Finance· 4 days agoReaders hoping to buy Pfizer Inc. (NYSE:PFE) for its dividend will need to make their move shortly,...
AstraZeneca withdrawing Covid vaccine, months after admitting rare side effect
The Telegraph via Yahoo News· 12 hours agoThe Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, months after the pharmaceutical...
Patient dies in Pfizer study of Duchenne gene therapy
BioPharma Dive via Yahoo Finance· 16 hours agoPfizer said the patient, a young boy who was treated earlier last year, had died suddenly. The...
Is Pfizer Stock Fully Valued At $28?
Forbes· 1 day agoPfizer (NYSE: PFE) reported its Q1 results last week, with revenues and earnings beating the street estimates.
Pfizer First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 22 hours agoPfizer (NYSE:PFE) First Quarter 2024 Results Key Financial Results Revenue: US$14.9b (down 19% from...